BIOCON
Back to All Ratios
|
BIOCON Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 1.27 | 1.13 | 3.25 | 4.29 | 3.65 |
What is the latest EV/CE ratio of BIOCON ?
Year | EV/CE |
---|---|
Mar2024 | 1.27 |
Mar2023 | 1.13 |
Mar2022 | 3.25 |
Mar2021 | 4.29 |
Mar2020 | 3.65 |
How is EV/CE of BIOCON Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 1.27 | 12.39 | |
Mar2023 | 1.13 | -65.23 | |
Mar2022 | 3.25 | -24.24 | |
Mar2021 | 4.29 | 17.53 | |
Mar2020 | 3.65 | - |
Other Financial Ratios of BIOCON
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹41,594.8 Cr | -1.1% | -1.8% | 40.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | -1.1% |
-1.8% |
40.4% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses